Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease;Ocena stȩżenia wisfatyny w surowicy dzieci z niealkoholowa̧ choroba̧ stŁuszczeniowa̧ wa̧troby

Polski Merkuriusz Lekarski

Volumn 28, Issue 168, 2010, Pages 459-461

  Romanowska, Anna ^a   Lebensztejn, Dariusz Marek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Children; Non alcoholic fatty liver disease (NAFLD); Obesity; Visfatin

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; INTERLEUKIN 6; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ARTICLE; BLOOD; CHILD; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; MALE; OBESITY; PROSPECTIVE STUDY;

ADIPOKINES; ADOLESCENT; BIOLOGICAL MARKERS; CHILD; FATTY LIVER; FEMALE; HUMANS; INTERLEUKIN-6; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PROSPECTIVE STUDIES;

EID: 77954676710     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Adams L.A. Sanderson S., Lindor K.D. i wsp.: The histological course of nonalcoholic fatty liver disease, a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol., 2005, 42, 132-138.
2. Aller R., de Luis D.A., Izaola O. i wsp.: Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease. Dig. Dis. Sci., 2009, 54, 1772-1777.
3. Araki S., Dobashi K., Kubo K. i wsp.: Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity, 2008, 16, 384-388.
4. Davutoglu M., Ozkaya M., Guler E. i wsp.: Plasma visfatin concentration in childhood obesity, relationships with insulin resistance and anthropometric indices. Swiss. Med. Wkly., 2009, 10, 22-27.
5. Fukuhara A., Matsuda M., Nishizawa M. i wsp.: Visfatin, a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307, 426-430.
6. Haider D.G., Holzer G., Schalter G. i wsp.: The adipokine visfatin is markedly elevated in obese children. J. Pediatr. Gastroenterol. Nutr., 2006, 43, 548-549.
7. Jarrar M.H., Baranova A., Collantes R. i wsp.: Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther., 2008, 27, 412-421.
8. Jin H., Jiang B., Tang J. i wsp.: Serum visfatin concentration in obese adolescents and its correlation with age and high-density lipoprotein cholesterol. Diabetes Res. Clin. Pract, 2008, 79, 412-428.
9. Kershaw E.E., Flier J.S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 2004, 89, 2548-2556.
10. Komer A., Garten A., Bluher M. i wsp.: Molecular characteristics of serum visfatin and differential detection by immunoassays. J. Clin. Endocrinol. Metab., 2007, 92. 4783-4791.
11. Krausen S., Klein J., Lossner U. i wsp.: Interieukin-6 is a negative regulator of visfatin gen expression in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metabol., 2005, 289, 586-590.
12. Louthan M.V., Theriot J.A., Zimmerman E. i wsp.: Decreased serum adiponectin, an early event in pediatric nonalcoholic fatty liver disease. J. Pediatr., 2005, 147, 835-838.
13. Mathiesen U.L., Franzen L.E., Aselius H. i wsp.: Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig. Liver Dis., 2002, 34, 516-522.
14. Moschen A.R., Kaser A., Enrich B. i wsp.: Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol., 2007, 178, 1748-1758.
15. Nakamuta M., Tada S., Uchimura K. i wsp.: Serum leptin levels in patients with nonalcoholic chronic liver disease. Hepatogastreonetrology, 2001, 48, 527-532.
16. Patton H.M., Sirlin C., Behling C. i wsp.: Pediatric nonalcoholic fatty liver disease, a critical appraisal of current data and implication for future research. J. Pediatr. Gastroenterol. Nutr., 2006, 43, 413-427.
17. Ratziu V., Charlotte F., Heurtier A. i wsp.: Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology, 2005, 128, 1898-1906.